Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of NeuroPace (NASDAQ:NPCE) through any online brokerage.
Other companies in NeuroPace’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
NeuroPace has a consensus price target of $17.69.
The stock price for NeuroPace (NASDAQ: NPCE) is $12.98 last updated October 13, 2026 at 9:39 AM EDT.
There are no upcoming dividends for NeuroPace.
NeuroPace does not have any upcoming earnings scheduled.
There is no upcoming split for NeuroPace.
NeuroPace is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.